Preparations of d,/-and meso-hexamethyl propyleneamine oxime (HM-PAO) labeled with techne tium-99m were added to rat brain homogenates diluted with phosphate buffer (l: 10). The conversion of d, / HM-PAO to hydrophilic forms took place with an initial rate constant of 0.12 min -1. Incubation of the brain ho mogenate with 2% diethyl maleate for 5 h decreased the homogenate's measured glutathione (GSH) concentration from 160 to 16 f.LM and decreased the conversion rate to 0.012 min -]. Buffered aqueous solutions of glutathione rapidly converted the HM-PAO tracers to hydrophilic forms having the same chromatographic characteristics as found in the brain homogenates. The rate constant for the conversion reaction of d,l-HM-PAO in GSH aqueous solution was 208 and 317 LlmoIlmin in two different assay systems and for meso-HM-PAO the values were 14.7 and 23.2 LlmoIlmin, respectively. Rat brain has a GSH con centration of about 2.3 mM and the conversion of the d,l-HM-PAO due to GSH alone should proceed with a
Over the last decade, several brain imaging ra diopharmaceuticals with sufficiently long brain res idence times to permit routine imaging by single photon emission computed tomography (SPECT) have been developed. These have included e2 3 I]_ labeled p-iodo-N -isopropylamphetamine (IMP) (Winchell et aI., 1980) and N ,N-dimethyl-N'(2hydroxy-5-iodo-3-methylbenzyl)-1 ,3-propanediamine (HIPDM) (Tramposch et aI., 1983) , eOITl] diethyldithiocarbamate (DDC) (Wyth et aI., 1983) S4 rate constant of 0.48 to 0.73 min -] and be correspond ingly 14-fold slower for meso-HM-PAO. In human brain, the in vivo data of Lassen et al. show a conversion rate constant of 0.80 min -]. This correspondence of values supports the notion that GSH may be important for the in vivo conversion of 99ffiTc-labeled HM-PAO to hydro philic forms and may be the mechanism of trapping in brain and other cells. A kinetic model for the trapping of d,l-and meso-HM-PAO in tissue is developed that is based on data of GSH concentration in various organs. This model predicts that the d,l form rapidly reaches a steady state in tissue and the tissue distribution reflects a pattern dominated by blood flow. For the meso form, the model predicts that steady state is reached more slowly and the tissue distribution reflects a pattern dominated by glutathione concentration. Key Words: Compartmental model-Regional cerebral blood flow-Single photon emission computed tomography-Technetium-99m-hexamethylpropyleneamine oxime-Glutathione. and [99mTc]hexamethylpropyleneamine oxime (HM-PAO) (Ell et al., 1985a; Nowotnik et al., 1985) . The e2 3 I] and [20ITl] labels each suffer from disad vantages. e2 3 !] is expensive and has limited avail ability, while eOITI] has physical properties that lead to poor quality images.
[99mTc] has none of these disadvantages and is the label of choice for most nuclear medicine investigations.
The development of [99mTc]-HM-PAO followed from the discovery of [99mTc]-propyleneamine ox ime (PnAO) (Fig. 1) by Troutner et al. (1984) . The [99mTc]-PnAO complex is stable, neutral, and li pophilic. Following intravenous injection, it crosses the blood-brain barrier (Canning et aI., 1985) to give transient flow images and then rapidly washes out (Holm et aI., 1985) . These images do not persist for long enough to permit SPECT with a rotating head 'Y camera, prompting the search for a PnAO ana-RETENTION MECHANISM OF t9mTc]-HM-PAO logue with a longer brain residence time. The eval uation of a large number of PnAO derivatives led to the selection of [99mTc]_HM_PAO (Neirinckx et aI., 1986) (Fig. I (Holmes et aI., 1985) and preliminary clinical work (Ell et aI., 1985a,b) have shown the primary complex to have a high uptake and long residence time in the brain. The HM-PAO ligand exists in two diastereoiso meric forms, d,1 and meso. The d,l diastereoisomer is a racemic mixture of d and I enantiomers. The separation of the HM-PAO diastereoisomers permit ted the synthesis and study of the [99mTc]_d,l_ and meso-HM-PAO complexes ( Fig. I) (Juris son et aI., 1985; Nowotnik et aI., 1985; Neirinckx et aI., 1987) . Both complexes are neutral, lipophilic, and unsta ble. The d,1 complex is more unstable than the meso complex. Studies in rats (Nowotnik et aI., 1985) and humans (Sharp et aI., 1986) have shown the d,1 com plex to have the higher brain uptake and minimal washout. When the d,1 complex is administered in travenously, approximately 70-80% of the primary complex reaching the brain crosses the blood-brain barrier (Andersen et aI., 1988a) . Once the primary complex has crossed the blood-brain barrier, its fate is determined by the competition between a rapid conversion to a nondiffusible form and wash-out to blood. These two routes of loss of diffusible complex are of approximately equal importance, leading to approximately one-half of the 99mTc en tering brain being trapped (Lassen et aI., 1988) .
The in vivo retention of [99mTc]_HM_PAO com plexes has been attributed to an intracellular con version to nondiffusible, hydrophilic complexes (N eirinckx et aI., 1987) , In aqueous solution, this conversion occurs more quickly for the d, l complex than for the meso complex (Hung et aI., 1987) , whereas the PnAO complex is very stable (Troutner et aI., 1984) . Although these in vitro reactions are too slow to account for the in vivo retentions of the complexes, the relative brain retentions follow the same order as the rates of decomposition. Thus, the proportions of intravenously injected d,l and meso complexes retained in human brain are 5 and 1.7%, respectively (Sharp et aI., 1986) , whereas [99mTc]_PnAO shows virtually no retention (Holm et aI., 1985) . This observation is consistent with the hypothesis that the in vivo retention of the [99mTc]_HM_PAO complexes are related to the in stabilities of the primary, lipophilic complexes,
We present evidence that the in vivo conversion of [99mTc]-d,l-HM-PAO to nondiffusible forms may be dominated by an intracellular reaction with glu tathione (GSH). GSH constitutes the bulk of all free thiols in mammalian tissue and is present in concen trations of 1-10 mM intracellularly but only about 10 f.LM in biological fluids such as plasma or bile (Kosower, 1976) . The rates of the reactions be tween GSH and the d,1 and meso complexes are measured and shown to be consistent with the ob served rate of loss of diffusible d, l complex in brain (Lassen et aI., 1988) (Ecobichon, 1984) and incubating at room temperature for 4-5 h. Control samples were treated similarly, except that no DEM was added.
Aliquots of both homogenates were taken for GSH de termination before and after reaction with [99mTc]_ d,/-HM-PAO. GSH was determined by extracting the ho mogenates with 4% aqueous sulfosalicylic acid, neutral izing and determining the absorption at 412 nm following incubation with I mM Ellman's reagent (Ellman, 1959) (Sigma Chemical Corp., St. Louis, MO, U.S.A.) in 75 mM, pH 7 phosphate buffer at room temperature for 30 min.
The [99mTcl-d,l-HM-PAO was prepared using a freeze dried formulation (Ceretec TM , Amersham International) according to the manufacturer's instructions and 0.1 ml portions of this solution were added to 5 ml aliquots of each of the homogenate preparations. The disappearance of primary, lipophilic complex was monitored by measur ing the octanol-extractable fraction of the 99mTc in 0.5 ml portions of the mixture taken from 1 to 25 min after mix ing (Andersen et aI., 1988b) and also by high pressure liquid chromatography (HPLC) (Neirinckx et aI., 1987) .
Measurement of the rates of the reactions of [ 99 mTc]d,l_ and meso-HM-PAO with GSH in vitro
A 5 mM solution of GSH in 10 mM phosphate buffer (pH 7.4) was prepared in a nitrogen atmosphere and di luted with N2-purged buffer to obtain solutions with GSH concentrations ranging from 0.01 to 5.00 mM. Five milli liter portions of these solutions were transferred to N2filled vials. Vials of 10 mM pH 7.4 phosphate buffer were used as controls. Solutions of [99mTcl-d,l-HM-PAO were prepared as described above. Solutions of [99mTc]_ meso-HM-PAO were prepared from a similar formula tion, in which the meso form of HM-PAO replaced the d,l diastereoisomer. One-half milliliter aliquots of either the d,l or meso complex were added to the GSH solutions and controls, all of which were incubated in a water bath at 37°C. [99mTc]-meso-HM-PAO was studied over the GSH concentration range of O. I to 5.0 mM and [99mTc]-d,l-HM-PAO over the GSH concentration range of 0.01 to 0.5 mM. (These limits were imposed because the rates of disappearance of the lipophilic complexes could be conveniently measured under these conditions.) Samples were taken at 2, 15, 30, 45, and 60 min, and subjected to the standard [99mTcJ-d,I-HM-PAO radio chemical purity measurement by thin-layer chromatogra phy (TLC) and HPLC (Neirinckx et aI., 1987) . Samples of the GSH solutions without added tracer were assayed spectrophotometrically, using the method of Grassetti and Murray (1967) , during the course of the experiment. In all, 41 vials containing d,l complex and GSH and three vials containing meso complex and GSH were each sam pled at the five time points.
RESULTS

Measurement of the effect of GSH depletion on the reaction time between [ 99 mTc]--d,I-HM-PAO and brain homogenate
The measured GSH contents of the control and DEM incubated homogenates varied from 0.16--0.15 mM and 16--14 f,LM, respectively. The octanol ex traction experiments showed that, in the control ho mogenates, the lipophilic complex disappeared with an initial rate constant of O. 12 ± 0.02 min-I. How ever, in the DEM-incubated homogenates, the li pophilic complex disappeared much more slowly,
with a rate constant of 0.0 12 ± 0.006 min -1. A fur ther control experiment confirmed that, in the ab sence of tissue, DEM had no influence on the sta bility of [99mTc]-d, I-HM-PAO.
The HPLC study (Fig. 2 , traces A and C) con firmed the conversion to a hydrophilic form in vitro.
The reactions of [ 99 mTc]--d,I_ and meso-HM-PAO with GSH in vitro Spectrophotometric assays showed that the free thiol concentrations in the vials containing no added 99mTc complex remained unchanged during the course of the experiments.
In the vials that contained [99mTc]_d, l_ or meso HM-PAO and GSH, radiochemical purity measure ments indicated that one of the reaction products interfered with the measurement of primary, li pophilic complex. As described by Neirinckx et al. (1987) , the proportion of primary, lipophilic com plex was assessed by TLC using two strips of LTLC/SG (Gelman). One strip was developed in 2butanone (MEK) and the other in 0.9% saline. In the absence of GSH, the interpretation of the chro- (1987) , TC04 -, reduced hydrolyzed technetmm, and very hydrophilic 99mTc complex (X) (Fig. 2 , tr aces A and B).
In the early stages of the reaction of both d, l and meso primary complexes (L � 80%) with GSH, the principal decomposition product was usually sec onde:y complex. After the reactions had proceeded to a substantial extent (L < 50%), the TC04 -con tent had increased substantially and X was detect able by HPLC as a shoulder on the Tc04 -peak. Quantitative comparison of HPLC with concurrent TLC studies indicated that X moved with Tc04 -in saline TLC but was immobile by MEK TLC. Hence, X could not be quantified in these chro matographic systems. Efforts to isolate X by a va riety of other techniques proved to be unsuccessful.
Defining P(1) = % MEK mobile -% saline mo bile and P(2) = % MEK mobile, then P(l) = % L -% X and P(2) = % L + % TC04 -; therefore, P(1) � % L � P(2). Hence, the assays P(2) and PO) provide higher and lower estimates, respectively, for L. For each GSH concentration employed, the initial rates -d In P(1)ldt and -d In P(2)ldt gave higher and lower estimates, respectively, for the rate of disappearance of L ( Fig. 3) . These rates were found to be proportional to GSH concentra tion allowing higher and lower estimates for the , 2 second order rate constants, kGSH [= -d InLl (d[GSH]dt)], for the reactions of d, l-and meso HM-PAO complexes to be calculated. Analysis 
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FIG. 3. Semilogarithmic plots of the disappearance of the lipophilic complex for the meso and the d,l diastereoisomers of r99mTcj-HM-PAO in aqueous medium. It should be noted that the GSH concentration was 42-fold greater in the meso incubation medium compared to that in the d,l incubation medium.
by the method of least mean squares gave, for the d, l complex, -d2InP (1) where the terms in P(1) and P(2) represent higher and lower estimates, respectively, for kGSH' As will be discussed later, the precisions with which the values of kGSH have been measured are adequate for the intended comparison with biological data. Using similar techniques to those described here, One of the principal intracellular functions of GSH is the detoxification of the electrophiles such as OEM (Ketterer et aI., 1983) . The depletion of tissue GSH arises by OEM acting as a substrate for the S-alkenetransferase, which adds GSH across an a,p-unsaturated bond (Chasseaud, 1976) . The de composition of the d, l complex in the brain homog enate that was not treated with OEM proceeded rapidly. The decomposition of the d, l complex in the DEM-treated homogenate was substantially slower, although much faster than in the absence of any brain homogenate. These findings indicate that, at normal tissue concentrations, a reaction medi ated by GSH may be the principal source of con version of primary [99mTc]-d, I-HM-PAO to the nondiffusible form in rat brain. When the GSH level is substantially depleted, the rate of conver sion is much slower and may be dominated by other sources of conversion that are of only minor impor tance at normal tissue GSH concentrations . The reactions of the primary d, l and meso com plexes with GSH in vitro produce changing mix tures that include the secondary complexes, Tc04 -, reduced hydrolyzed technetium, and an un identified complex (or complexes), X. It may be that X is a [99mTc]_GSH complex but, while X can-not be isolated in high radiochemical purity, this must remain as conjecture. Studies at the Amer sham Laboratories of the decomposition of primary [99mTc]-d,I-HM-PAO in aqueous solution (Nech vatal et aI., unpublished results) have shown that, at these higher Tc concentrations, the decomposition produces different, possibly oligomeric, products. The chromatographic evidence suggests that X may be a decomposition product of secondary, rather than primary, complex. These observations indi cate that studies with [99mTc] are unlikely to identify X. However, despite these difficulties, the experi ments have permitted definition of the ranges within which the values of kGSH lie for each of the d, l and meso complexes. If reaction with GSH is the rate determining step for the intracellular conversion of [99mTc ]-HM -P AO complexes to nondiffusible forms, the rates measured in vitro may be combined with known tissue GSH concentrations to predict the in vivo behavior of the d, l and meso complexes. These predictions may be compared with clinical findings.
Comparisons of the predicted in vivo behavior with clinical findings
Tissue GSH concentrations
For human whole blood, [GSH] = 1. 2 mM (Tietze, 1969) . Very few literature references for the values of GSH concentration in other human tissues have been found. Such information as is available comes either from postmortem or dis eased tissue biopsy samples. Diseased tissue sam ples are unrepresentative of normal volunteers and the postmortem samples had not been processed with the ral>idity required to l>revent inaccuracies due to metabolic and oxidative losses of GSH (Anderson, 1985) . Since the reported organ GSH concentration values for rats, mice, guinea pigs, and rabbits show little interspecies difference (Fernandez and Videla, 1981; Ecobichon, 1984; Ka plan et aI., 1980; Guerri and Grisolia, 1980; Tom et aI., 1985; Thomson and Martin, 1959; McIlwain, 1959; Meister, 1975; Chasseaud, 1976; Meister, 1983) , human values for GSH concentration have been estimated by averaging those reported in ani mal studies: [GSH] = 2. 3 mM for the brain, 1. 6 mM for the lungs, 1. 9 mM for the heart, 7.0 mM for the liver, and 2.5 mM for the gastrointestinal tract.
Biochemical effects of [99mTc]-d, I-HM-PAO administration
A typical 500 MBq (13. 5 mCi) dose of 99mTc con tains approximately 10-10 mol of technetium. Since GSH exists in mammalian cells in mM concentra tions and is maintained by the 'Y-glutamyl cycle (Meister, 1974) , the administration of [99mTc]_ J Cereb Blood Flow Metab, Vol. 8, Suppl. 1, 1988 d,l-HM-PAO should not cause any ill effects in pa tients by inducing a GSH deficit.
The rate of conversion of [ 99 mTc]-d, I-HM-PAO in human brain
Lassen et ai. (1988) find k3' the first-order rate constant describing the conversion of primary d, l complex in brain to nondiffusible forms, to be 0. 80 ± 0. 12 (SD) min -1. If reaction with GSH is the rate-determining step for this conversion, k3 = kGSH [GSH], where [GSH] is the concentration of GSH in brain and may be assumed to be unaltered by the reactions since GSH is present in vast ex cess. With [GSH] = 2.3 mM and kGSH = 208-317 Limol/min, k3 is calculated to be 0.48-0.73 min -1. The agreement between predicted and clinical rates is satisfactory.
The human organ retentions of [99mTc]_d, l_ and meso-HM-PAO
The Appendix describes the use of a compart mental model for predicting the human organ distri butions of the [99mTc]-HM-PAO complexes. Table  1 lists the first-order rate constants derived from known tissue perfusion rates, the tissue GSH con centrations derived above, and the measured values of kGSH' The uncertainties in the measured values of kGSH are described by reporting higher and lower estimates for the derived values of k3 and k5 [Eqs.
(Al) and (A2)]. These rate constants have been used to calculated the parameters e-k5T, V, and R described in the Appendix and listed in Table 2 . It is seen that, in most cases, e -k l T , V, and E are close to unity. Andersen et al. (1988a) find that [99mTc}-d,I-HM-PAO decomposes in human whole blood in biexponential fashion with approximately equal components of half-lives 1.7 and 7. 4 min. In human plasma, biexponential decomposition was seen with approximately equal components of half lives 1. 4 and 24.4 min. The model used here pre dicts monoexponential decomposition in whole blood with a half-life of 1. 8-2. 8 min. Since the tran sit times T, are short, the blood correction de scribed here by e -k , T will be close to unity for any of the half-lives noted. Andersen et al. attribute the biexponential behavior to differences in the rates of reaction of d and I enantiomers in blood. This may be the result of differential protein binding. The ex istence of the fast component in plasma suggests an alternative decomposition route in plasma since the GSH concentration is only approximately 10 fl-M.
The major factors influencing the organ reten tions D [Eq. (A3)} are the radiochemical purity of the irijected material L, the proportion of cardiac output delivered to the organ C, and the retained fraction R. The reported higher and lower estimates for e -k5T, V, and R (Table 2) reflect the uncertain ties in k GSH' It is seen that the measured uncertain ties have a minimal effect on e -k5T and V and only a relatively weak influence on R for the d, l com plex. Thus, the calculated organ distributions for the d, l complex are relatively insensitive to the un certainties in kGs�what is important is that k GSH ( = 208-317 Llmollmin) is high (although not so high that k5 is large enough for substantial blood reten-tion). For the meso complex, k GSH ( = 14.7-23.2 Llmollmin) is an order of magnitude lower, k3 � k2' and Eq. (A4) may be approximated to R = k31k2'
Thus, for the meso complex and for the d, l complex in lung, washout accounts for the fate of most of the primary complex that enters cellular tissue and the organ retention [Eq. (A3)} may be approximated to D = CLEk3Ik2. With C = mf/F, where m is the organ mass and F the total cardiac output, Dim = k3LA.IF and the density of distribution of the meso complex is predicted to be a map of k3 or organ GSH con centration. For the d, l complex in organs other than lung, D = CLER, giving Dim = f LIF(1/E + f/A.k3).
If k3 � f/A., the density of distribution within an organ would be a true relative flow map. In prac tice, k3 = f/A. and, although the image is flow re lated, a true relative flow map would be achieved by the linearization technique of Lassen et al. (1988) . Table 2 reports the calculated values of the organ retentions D. These are compared with clinically measured distributions. For [99mTc}-d, I-HM-PAO, the data are from 22 normal volunteers studied in a total of four European institutions and are reported as means ± SD. For [99mTc}-meso-HM-PAO, the data refer to two normal volunteers (Sharp et al., 1986) . The percentages of the injected dose of ra diopharmaceutical retained in each organ were es timated from quantitative analysis of planar images and corrected for intravascular radioactivity. There is a very good agreement between the predicted first-pass retentions and measured retentions of [99mTc}-d, l-HM-PAO in the brain, heart, and liver. This points to minimal recirculation from the tis-sues, in agreement with the rapid disappearance of [99ffiTc]-d,I-HM-PAO from arterial blood reported by Andersen et al., (1988b) . The agreement be tween predicted and measured lung retentions is not as good. This discrepancy may be due to the lack of correction for soft tissue background in some of the clinical studies and to the high lung activities as sociated with tobacco-smoking normal volunteers noted by Sharp et al. (1986) . With [99ffiTc] meso-HM-PAO, we also found good agreement be tween predicted and measured retentions in the brain. However, the clinical sample size of two vol unteers is too small to justify detailed comparison.
Overall, the agreement between predicted and measured disturbances is satisfactory. J Cereb Blood Flow Me/ab, Vol. 8, Suppl. 1, 1988 complex in the blood is a simplification. Red blood cells contain the blood GSH pool (Tietze, 1969) , and clinical evidence suggests that these cells are the principal site of trapping in the blood (Sharp et al., 1986) .
The clearance KJ for the uptake of e9ffiTc]_ HM-PAO by tissue is calculated as KJ = fE, where f = tissue perfusion (volume flow rate per unit mass of tissue) and E = extraction efficiency. Values for f were obtained from Davson and Eggleton (1968) . According to Crone (1963) , E = 1 -e -ps/f, where S = specific surface area of capillaries and P = cap illary permeability coefficient for [99ffiTc]_HM_ PAO.
The first-order rate constant k2 for the wash-out of the 99ffiTc-Iabeled freely diffusible, lipophilic complex from the tissue to blood is calculated as k2 = K/II. = fE/A, where A is the partition coefficient (Kety, 195 1) . A value for A of 1.0 mllg is used on the assumption that the complexes are equally soluble in blood and cytoplasm.
On the assumption that reaction with GSH is the major rate-determining step for the conversion of primary [99ffiTc]_HM_PAO complexes to nondiffus ible forms, the first-order rate constants k3 and k5 Following intravenous injection, the blood carry ing the tracer will pass, via the right side of the heart, to the lungs and then to the left side of the heart. From the left side of the heart, it will be distributed around the body according to the distri bution of cardiac output. The first pass in vivo dis tribution D of [99ffiTc]_HM_PAO is calculated as
where D = proportion of injected dose of [99ffiTc]-HM-PAO that is retained at the first pass of each organ, L = radiochemical purity of the Values of L, the radiochemical purity at the time of injection, were determined by TLC (Neirinckx et aI., 1987) and were 87% for [99mTc]-d, l-HM-PAO and 92% for [99mTc]-meso-HM-PAO.
Delay times T were derived from clinically mea sured transit times from injection site to each organ: T = 0.30 min for the brain, 0. 17 min for the lungs, 0.20 min for the heart, and 0.30 min for the liver.
Values for C, the fractional cardiac output to each organ, are given by Winton and Baylisse (1962) : C = 100% for the lungs (ignoring the small contribution of bronchial circulation), 3% for the heart, and 30% for the liver. There is much dis agreement in the literature over the cardiac output to the brain. A value of 12% was derived from brain weight and total cardiac output (Snyder et aI., 1975) , and from tissue perfusions values (Davson and Eggleton, 1968 ).
Andersen et al. have determined the value of E for [99mTc]-d, l-HM-PAO entering the human brain as 0.72 for a flow of 0.54 mllg/min (Andersen et aI., 1988a) . The brain may be presumed to have a con siderably lower permeability (Crone and Thomp son, 1970 ) and a lower capillary surface area (Kety, 195 1) than other organs. Consequently, the extrac tion efficiencies for [99mTc]-d, l-HM-PAO entering the lungs, heart, liver, and gastrointestinal tract have been assumed to be unity. Since the mem brane permeability of a passively transported mol ecule depends mainly upon the molecule's size and lipophilicity, the extraction efficiencies for [99mTc]-meso-HM-PAO were assumed to be iden tical to those of the d, l diastereoisomer. [Note that the high blood flow in the lungs renders the assump tion of complete extraction dubious. The true ex traction may be substantially lower. However, even if the extraction efficiency for the lungs were only 0.2, that would produce, at worst, only a 15% de crease in the calculated lung activity, and a minute change in (1 -ELRL), used below to calculate V.]
The fraction V of lipophilic complex that is re tained in blood after passing other vascular tissues prior to reaching the organ is 1 for the lungs. For the heart and brain, V = 1 -ELRL, where EL is the ex traction efficiency of the lungs and RL is the fraction of the lipophilic complex that, having entered the lungs, is retained there. Since the liver receives about 75% of its blood supply from the portal vein (Winton and Baylisse, 1962) , a fraction of the [99mTc]-HM-PAO complex en route to the liver will be lost to the gastrointestinal tract. Consequently, for the liver, V = (1 -ELRd (1 -0.75 EaRa) ·
The fraction R of [99mTc]-HM-PAO molecules entering each organ that is retained, or trapped, is calculated as R = lim �t ---> oo ) Nt 
